{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/stroke-tia/goals-outcome-measures/qof-indicators/","result":{"pageContext":{"chapter":{"id":"4eb59f42-29b3-56e1-993f-1ce8ab7b2969","slug":"qof-indicators","fullItemName":"QOF indicators","depth":2,"htmlHeader":"<!-- begin field aaffe08a-c8b3-4e82-8afa-059aa214d356 --><h2>QOF indicators</h2><!-- end field aaffe08a-c8b3-4e82-8afa-059aa214d356 -->","summary":null,"htmlStringContent":"<!-- begin item 34396289-9750-4339-86cd-69be4c81f36d --><!-- begin field 2d4b788e-df63-41f9-b0d6-9d560a02911c --><p><strong>Table 1. </strong>Indicators related to stroke and transient ischaemic attack in the Quality and Outcomes Framework (QOF) of the General Medical Services (GMS) contract.</p><table><thead><tr><th scope=\"col\">Indicator</th><th scope=\"col\">Points</th><th scope=\"col\">Achievement threshold</th></tr></thead><tbody><tr><td><strong>Records</strong></td><td> </td><td> </td></tr><tr><td>STIA001. The contractor establishes and maintains a register of patients with stroke or TIA </td><td>2</td><td> </td></tr><tr><td><strong>Initial diagnosis</strong></td><td> </td><td> </td></tr><tr><td>STIA008. The percentage of patients with a stroke or TIA (diagnosed on or after 1 April 2014) who have a record of a referral for further investigation between 3 months before or 1 month after the date of the latest recorded stroke or the first TIA </td><td>2</td><td>45–80%</td></tr><tr><td><strong>Ongoing management</strong></td><td> </td><td> </td></tr><tr><td>STIA003. The percentage of patients with a history of stroke or TIA in whom the last blood pressure reading (measured in the preceding 12 months) is 150/90 mmHg or less </td><td>5</td><td>40–75%</td></tr><tr><td>STIA007. The percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record in the preceding 12 months that an antiplatelet agent, or an anti-coagulant is being taken</td><td>4</td><td>57–97%</td></tr><tr><td>STIA009. The percentage of patients with stroke or TIA who have had influenza immunisation in the preceding 1 August to 31 March</td><td>2</td><td>55–95%</td></tr><tr><td colspan=\"3\"><strong>Data from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">BMA and NHS Employers, 2016</a>]</td></tr></tbody></table><!-- end field 2d4b788e-df63-41f9-b0d6-9d560a02911c --><!-- end item 34396289-9750-4339-86cd-69be4c81f36d -->","topic":{"id":"f543bb01-4edc-57a6-ba31-aaa6b6b6e6e8","topicId":"63954e32-591d-4f33-bcbb-3fdecfc69796","topicName":"Stroke and TIA","slug":"stroke-tia","lastRevised":"Last revised in August 2020","chapters":[{"id":"3690cd7d-0a6b-548a-a527-b276c3924bab","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"aef0c419-4ee2-52b6-b781-c8afa9a11104","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f8baebfc-07d7-5c4a-8d95-4d2bf1f42c38","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3fa3210c-0be8-5167-adb3-6c05aaef00bc","slug":"changes","fullItemName":"Changes"},{"id":"e606f403-4b76-5e30-a38d-6aa4b6e3b4b1","slug":"update","fullItemName":"Update"}]},{"id":"fe337d01-2447-58d3-93e8-a6b09a4920d4","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"08277b76-a6c4-566a-a594-131c32067735","slug":"goals","fullItemName":"Goals"},{"id":"acf4fa85-325c-5018-8bc2-9d877522bf6f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"18bc44dc-3e6b-58ae-9d3c-abca76b13c16","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4eb59f42-29b3-56e1-993f-1ce8ab7b2969","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"08107877-662b-59e6-a30a-b21e19250f23","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ff061807-ab05-5af8-8dd4-01db71526d0f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a0b319c1-8df3-5206-93ce-302f6b981e82","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a0bcd779-defb-50a7-86f6-ab4b2c701ac7","slug":"definition","fullItemName":"Definition"},{"id":"c40d717d-0b67-5cb2-b86c-c67045400115","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"d1569ff2-5da1-51a0-9720-75ad88c0ad86","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"ee8fc150-6899-5c75-a0d0-6241055dfd09","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d5730239-5d67-598b-b9d1-f339079de3eb","slug":"complications","fullItemName":"Complications"},{"id":"9b730ca3-d3ee-552b-8145-f6eadf244a63","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"caea5ae7-0be8-5c7c-8bef-7162c7171e9d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"67902a93-a36b-58c6-a67a-3eb89654460c","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"2bc808d1-f905-575d-90b2-8481eb492905","slug":"assessment","fullItemName":"Assessment"},{"id":"6562a8bf-1396-58ba-b1b9-a1914e4adebe","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"2d634696-3361-5fd3-b676-609f3c31c2f1","fullItemName":"Management","slug":"management","subChapters":[{"id":"1baf2362-0da4-599f-8f9a-12d0124253a0","slug":"suspected-acute-stroke","fullItemName":"Scenario: Suspected acute stroke"},{"id":"15af1682-8287-57f9-90f1-954c1f71792e","slug":"suspected-transient-ischaemic-attack","fullItemName":"Scenario: Suspected transient ischaemic attack"},{"id":"91d820f4-4249-556c-99e2-4ac86d3ebd2a","slug":"secondary-prevention-following-stroke-tia","fullItemName":"Scenario: Secondary prevention following stroke and TIA"},{"id":"84ca3884-d693-5209-b048-6ff53b4ae2be","slug":"management-of-long-term-complications-of-stroke","fullItemName":"Scenario: Management of long term complications of stroke"}]},{"id":"30a83b67-7804-5b41-a647-98d32dce018a","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"ebfe1dbe-0d9c-5a26-82b4-4d0a308a19ac","slug":"antiplatelet-treatment","fullItemName":"Antiplatelet treatment"}]},{"id":"279444c7-61df-5f92-b512-c703ae6cb9fb","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8ef8b6ac-1d47-5038-b4d7-4d77faf1a823","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"72590587-c86f-5da1-b397-b7e6cc757702","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7ba85ca6-985e-5af5-b223-0c27f7066797","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b322154e-a2d3-59d1-a7b2-d70b4e7812da","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"18f7eefe-52bd-5ad8-a39c-b96d270599ff","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8fed8545-5194-53a4-b547-2d6a402857f5","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"216e65b7-f638-5b35-ad86-30270fbea649","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"fe337d01-2447-58d3-93e8-a6b09a4920d4","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}